We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$87.7M
VVM
2
Versant Venture Management
California
$33M
DM
3
Deerfield Management
New York
$25.6M
RG
4
Redmile Group
California
$15.2M -$1.45M -83,890 -9%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$10.3M -$18.7K -1,084 -0.2%
AllianceBernstein
6
AllianceBernstein
Tennessee
$9.74M -$563K -32,580 -6%
RCM
7
RA Capital Management
Massachusetts
$9.73M -$3.02M -175,000 -25%
RSCM
8
Rock Springs Capital Management
Maryland
$8.86M
BFA
9
BlackRock Fund Advisors
California
$8.74M +$5.61M +324,656 +211%
VMI
10
VHCP Management II
New York
$8.25M
CAM
11
Cormorant Asset Management
Massachusetts
$8.21M
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$8.07M
Franklin Resources
13
Franklin Resources
California
$6.71M
Fidelity Investments
14
Fidelity Investments
Massachusetts
$6.39M
Jennison Associates
15
Jennison Associates
New York
$5.47M +$18.5K +1,070 +0.4%
Vanguard Group
16
Vanguard Group
Pennsylvania
$4.97M +$557K +32,231 +13%
EAM
17
Eventide Asset Management
Massachusetts
$4.11M
BA
18
BlackRock Advisors
Delaware
$3.72M +$61.3K +3,549 +2%
JP Morgan Chase
19
JP Morgan Chase
New York
$2.26M -$116K -6,726 -5%
BG
20
BlackRock Group
United Kingdom
$1.86M
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$1.82M -$377K -21,840 -18%
Millennium Management
22
Millennium Management
New York
$1.6M +$1.52M +87,755 New
FCMI
23
Foresite Capital Management III
California
$1.22M
State Street
24
State Street
Massachusetts
$1.15M +$475K +27,480 +77%
Northern Trust
25
Northern Trust
Illinois
$881K +$833K +48,237 New